GDB first oral macromolecule delivery international patent application was published in China.

GDB is pleased to announce that the first oral macromolecule deliveryinternational patent application (International Application NumberPCT/CN2022/126156) enter into the publication status in China. The publicationdate is June 21, 2024. This is the first patent application generated under theself-developed MO-PION technology platform, aiming to protect the key recipeand technology process of the platform. The application will enter into thenational phase of China, US, EU, and Japan et. al. under the PCT pathway.